DavidPerlmutterMD · 2026-08-19 · David Perlmutter (host), Emma Heming Willis, Nicole Beurkens
Why Women Should Start Protecting Their Brain Now with Dr. Nicole Beurkens & Emma Heming Willis
18 research-tied claims examined: 2 overstated 3 context 11 supported 2 unverified
2 No source found (not proven false)
OptoCeutics' EVY LIGHT 40 Hz light device achieves a 94% adherence rate and produces significant improvements in mood, energy, focus, sleep, and memory.
"And that's why this company sees a 94% adherence rate, uh, and significant improvements across various metrics including mood, energy, focus, sleep, and memory. And, uh, the light is called the EVY LIGHT." (said at 0:19:05)
No published record matching the claim that OptoCeutics' EVY LIGHT device achieves a 94% adherence rate and produces significant improvements in mood, energy, focus, sleep, and memory was located; this does not prove the claim false. Published literature on OptoCeutics' invisible spectral flicker technology consists primarily of technical feasibility and electroencephalography studies measuring visual evoked potentials in healthy volunteers, alongside published protocols for ongoing clinical trials in Alzheimer's disease and major depression.
Approximately 30% of caregivers die before the loved ones they care for.
"And there is this also this percentage that 30% of caregivers do die before their loved ones." (said at 0:56:16)
No published record matching the claim that approximately 30% of caregivers die before the loved ones they care for was located; this does not prove the claim false. While landmark observational studies (such as the Caregiver Health Effects Study) have evaluated mortality risks associated with caregiver strain, published epidemiological data verifying a specific 30% pre-deceased rate among informal caregivers were not identified.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.